Stay updated on Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Sign up to get notified when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No additions or deletions detected; the screenshots show the same study details and page layout.
    Difference
    0.2%
    Check dated 2026-02-20T16:50:27.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.4.2 released. No visible changes to the study details or navigation.
    Difference
    0.3%
    Check dated 2026-02-13T15:28:34.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no visible content changes to the study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-06T09:22:21.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    No additions or deletions were observed on the Study Details page. The page content appears unchanged relative to the MIT-E study information.
    Difference
    0.2%
    Check dated 2026-01-29T18:51:21.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The changes appear to be layout and formatting updates to the study page without changes to key trial details like criteria or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-22T09:29:38.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-15T05:00:29.000Z thumbnail image

Stay in the know with updates to Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.